+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Apheresis Market By Product, By Method, By Procedure, By Component, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 270 Pages
  • May 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640440
Description Jump to:
The global Apheresis market was valued at $ 2383.41 million in 2021, and is projected to reach $ 5300.57 million by 2031, registering a CAGR of 8.3% from 2022 to 2031.

Apheresis procedures involve separation of desired components from the blood, while the remaining is either returned to the donor or the patient. For a donor, apheresis may be used to collect a particular blood component such as platelets or plasma. For a patient apheresis may be used to remove a disease provoking component of blood. After removing a blood component, the remaining blood components are then returned into the bloodstream of the patient or donor.

Use of large-scale plasma donations in the treatment of trauma patients, burn victims, and patients suffering from serious illness or injuries primarily contributes toward the growth of the apheresis market. In addition, rise in prevalence of cancer and surge in number of patients undergoing surgery have increased the number of plateletpheresis across the globe, thereby supplementing the market growth. However, dearth of skilled professionals and post-procedural complications associated with apheresis are anticipated to hamper the market growth. On the contrary, advancements in the healthcare sector in emerging economies are expected to offer significant profitable opportunities for the market players.
Apheresis market is segmented into product, method, procedure, component, end user, and region. On the basis of product, the market is classified into devices, disposable & reagents, and software. By method, it is categorized into centrifugation, membrane separation, and selective adsorption. Depending on procedure, it is divided into donor/automated apheresis and therapeutic apheresis. According to component, it is fragmented into plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), and RBCS (erythropheresis). By end user, it is segmented into blood centers, hospitals, and others include academic institutions, research institutes (blood institutes), and biopharmaceutical manufacturers.

By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi, Haemonetics Corporation, Charles River Laboratories International, Inc, Kaneka Corporation, Kawasumi Laboratories Inc, Nikkiso Co. Ltd, Terumo BCT.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the apheresis market analysis from 2022 to 2031 to identify the prevailing apheresis market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the apheresis market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global apheresis market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Product

  • Devices
  • Disposable and Reagents
  • Software

By Method

  • Centrifugation
  • Membrane Separation
  • Selective Adsorption

By Procedure

  • Donor/Automated Apheresis
  • Therapeutic Apheresis

By Component

  • Plasma (Plasmapheresis)
  • Platelets (Plateletpheresis)
  • Leukocytes (Leukapheresis or leukopheresis)
  • Lymphocytes (Lymphopheresis or lymphapheresis)
  • RBC's (Erythropheresis)

By End User

  • Blood Centers
  • Hospitals
  • Other End Users

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Haemonetics Corporation
  • Fresenius Kabi
  • Terumo BCT, Inc
  • Asahi Kasei Medical Co., Ltd
  • Kaneka Corporation
  • Kawasumi Laboratories Inc
  • Cerus Corporation
  • B. Braun Melsungen AG
  • Nikkiso Co., Ltd
  • Charles River Laboratories International, Inc.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: APHERESIS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Disposable and Reagents
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Software
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: APHERESIS MARKET, BY METHOD
5.1 Overview
5.1.1 Market size and forecast
5.2 Centrifugation
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Membrane Separation
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Selective Adsorption
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: APHERESIS MARKET, BY PROCEDURE
6.1 Overview
6.1.1 Market size and forecast
6.2 Donor/Automated Apheresis
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Therapeutic Apheresis
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: APHERESIS MARKET, BY COMPONENT
7.1 Overview
7.1.1 Market size and forecast
7.2 Plasma (Plasmapheresis)
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Platelets (Plateletpheresis)
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Leukocytes (Leukapheresis or leukopheresis)
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Lymphocytes (Lymphopheresis or lymphapheresis)
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
7.6 RBC's (Erythropheresis)
7.6.1 Key market trends, growth factors and opportunities
7.6.2 Market size and forecast, by region
7.6.3 Market analysis by country
CHAPTER 8: APHERESIS MARKET, BY END USER
8.1 Overview
8.1.1 Market size and forecast
8.2 Blood Centers
8.2.1 Key market trends, growth factors and opportunities
8.2.2 Market size and forecast, by region
8.2.3 Market analysis by country
8.3 Hospitals
8.3.1 Key market trends, growth factors and opportunities
8.3.2 Market size and forecast, by region
8.3.3 Market analysis by country
8.4 Other End Users
8.4.1 Key market trends, growth factors and opportunities
8.4.2 Market size and forecast, by region
8.4.3 Market analysis by country
CHAPTER 9: APHERESIS MARKET, BY REGION
9.1 Overview
9.1.1 Market size and forecast
9.2 North America
9.2.1 Key trends and opportunities
9.2.2 North America Market size and forecast, by Product
9.2.3 North America Market size and forecast, by Method
9.2.4 North America Market size and forecast, by Procedure
9.2.5 North America Market size and forecast, by Component
9.2.6 North America Market size and forecast, by End User
9.2.7 North America Market size and forecast, by country
9.2.7.1 U.S.
9.2.7.1.1 Market size and forecast, by Product
9.2.7.1.2 Market size and forecast, by Method
9.2.7.1.3 Market size and forecast, by Procedure
9.2.7.1.4 Market size and forecast, by Component
9.2.7.1.5 Market size and forecast, by End User
9.2.7.2 Canada
9.2.7.2.1 Market size and forecast, by Product
9.2.7.2.2 Market size and forecast, by Method
9.2.7.2.3 Market size and forecast, by Procedure
9.2.7.2.4 Market size and forecast, by Component
9.2.7.2.5 Market size and forecast, by End User
9.2.7.3 Mexico
9.2.7.3.1 Market size and forecast, by Product
9.2.7.3.2 Market size and forecast, by Method
9.2.7.3.3 Market size and forecast, by Procedure
9.2.7.3.4 Market size and forecast, by Component
9.2.7.3.5 Market size and forecast, by End User
9.3 Europe
9.3.1 Key trends and opportunities
9.3.2 Europe Market size and forecast, by Product
9.3.3 Europe Market size and forecast, by Method
9.3.4 Europe Market size and forecast, by Procedure
9.3.5 Europe Market size and forecast, by Component
9.3.6 Europe Market size and forecast, by End User
9.3.7 Europe Market size and forecast, by country
9.3.7.1 Germany
9.3.7.1.1 Market size and forecast, by Product
9.3.7.1.2 Market size and forecast, by Method
9.3.7.1.3 Market size and forecast, by Procedure
9.3.7.1.4 Market size and forecast, by Component
9.3.7.1.5 Market size and forecast, by End User
9.3.7.2 France
9.3.7.2.1 Market size and forecast, by Product
9.3.7.2.2 Market size and forecast, by Method
9.3.7.2.3 Market size and forecast, by Procedure
9.3.7.2.4 Market size and forecast, by Component
9.3.7.2.5 Market size and forecast, by End User
9.3.7.3 U.K.
9.3.7.3.1 Market size and forecast, by Product
9.3.7.3.2 Market size and forecast, by Method
9.3.7.3.3 Market size and forecast, by Procedure
9.3.7.3.4 Market size and forecast, by Component
9.3.7.3.5 Market size and forecast, by End User
9.3.7.4 Italy
9.3.7.4.1 Market size and forecast, by Product
9.3.7.4.2 Market size and forecast, by Method
9.3.7.4.3 Market size and forecast, by Procedure
9.3.7.4.4 Market size and forecast, by Component
9.3.7.4.5 Market size and forecast, by End User
9.3.7.5 Spain
9.3.7.5.1 Market size and forecast, by Product
9.3.7.5.2 Market size and forecast, by Method
9.3.7.5.3 Market size and forecast, by Procedure
9.3.7.5.4 Market size and forecast, by Component
9.3.7.5.5 Market size and forecast, by End User
9.3.7.6 Rest of Europe
9.3.7.6.1 Market size and forecast, by Product
9.3.7.6.2 Market size and forecast, by Method
9.3.7.6.3 Market size and forecast, by Procedure
9.3.7.6.4 Market size and forecast, by Component
9.3.7.6.5 Market size and forecast, by End User
9.4 Asia-Pacific
9.4.1 Key trends and opportunities
9.4.2 Asia-Pacific Market size and forecast, by Product
9.4.3 Asia-Pacific Market size and forecast, by Method
9.4.4 Asia-Pacific Market size and forecast, by Procedure
9.4.5 Asia-Pacific Market size and forecast, by Component
9.4.6 Asia-Pacific Market size and forecast, by End User
9.4.7 Asia-Pacific Market size and forecast, by country
9.4.7.1 Japan
9.4.7.1.1 Market size and forecast, by Product
9.4.7.1.2 Market size and forecast, by Method
9.4.7.1.3 Market size and forecast, by Procedure
9.4.7.1.4 Market size and forecast, by Component
9.4.7.1.5 Market size and forecast, by End User
9.4.7.2 China
9.4.7.2.1 Market size and forecast, by Product
9.4.7.2.2 Market size and forecast, by Method
9.4.7.2.3 Market size and forecast, by Procedure
9.4.7.2.4 Market size and forecast, by Component
9.4.7.2.5 Market size and forecast, by End User
9.4.7.3 India
9.4.7.3.1 Market size and forecast, by Product
9.4.7.3.2 Market size and forecast, by Method
9.4.7.3.3 Market size and forecast, by Procedure
9.4.7.3.4 Market size and forecast, by Component
9.4.7.3.5 Market size and forecast, by End User
9.4.7.4 Australia
9.4.7.4.1 Market size and forecast, by Product
9.4.7.4.2 Market size and forecast, by Method
9.4.7.4.3 Market size and forecast, by Procedure
9.4.7.4.4 Market size and forecast, by Component
9.4.7.4.5 Market size and forecast, by End User
9.4.7.5 South Korea
9.4.7.5.1 Market size and forecast, by Product
9.4.7.5.2 Market size and forecast, by Method
9.4.7.5.3 Market size and forecast, by Procedure
9.4.7.5.4 Market size and forecast, by Component
9.4.7.5.5 Market size and forecast, by End User
9.4.7.6 Rest of Asia-Pacific
9.4.7.6.1 Market size and forecast, by Product
9.4.7.6.2 Market size and forecast, by Method
9.4.7.6.3 Market size and forecast, by Procedure
9.4.7.6.4 Market size and forecast, by Component
9.4.7.6.5 Market size and forecast, by End User
9.5 LAMEA
9.5.1 Key trends and opportunities
9.5.2 LAMEA Market size and forecast, by Product
9.5.3 LAMEA Market size and forecast, by Method
9.5.4 LAMEA Market size and forecast, by Procedure
9.5.5 LAMEA Market size and forecast, by Component
9.5.6 LAMEA Market size and forecast, by End User
9.5.7 LAMEA Market size and forecast, by country
9.5.7.1 Brazil
9.5.7.1.1 Market size and forecast, by Product
9.5.7.1.2 Market size and forecast, by Method
9.5.7.1.3 Market size and forecast, by Procedure
9.5.7.1.4 Market size and forecast, by Component
9.5.7.1.5 Market size and forecast, by End User
9.5.7.2 Saudi Arabia
9.5.7.2.1 Market size and forecast, by Product
9.5.7.2.2 Market size and forecast, by Method
9.5.7.2.3 Market size and forecast, by Procedure
9.5.7.2.4 Market size and forecast, by Component
9.5.7.2.5 Market size and forecast, by End User
9.5.7.3 South Africa
9.5.7.3.1 Market size and forecast, by Product
9.5.7.3.2 Market size and forecast, by Method
9.5.7.3.3 Market size and forecast, by Procedure
9.5.7.3.4 Market size and forecast, by Component
9.5.7.3.5 Market size and forecast, by End User
9.5.7.4 Rest of LAMEA
9.5.7.4.1 Market size and forecast, by Product
9.5.7.4.2 Market size and forecast, by Method
9.5.7.4.3 Market size and forecast, by Procedure
9.5.7.4.4 Market size and forecast, by Component
9.5.7.4.5 Market size and forecast, by End User
CHAPTER 10: COMPANY LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product Mapping of Top 10 Player
10.4. Competitive Dashboard
10.5. Competitive Heatmap
10.6. Key developments
CHAPTER 11: COMPANY PROFILES
11.1 Haemonetics Corporation
11.1.1 Company overview
11.1.2 Company snapshot
11.1.3 Operating business segments
11.1.4 Product portfolio
11.1.5 Business performance
11.1.6 Key strategic moves and developments
11.2 Fresenius Kabi
11.2.1 Company overview
11.2.2 Company snapshot
11.2.3 Operating business segments
11.2.4 Product portfolio
11.2.5 Business performance
11.2.6 Key strategic moves and developments
11.3 Terumo BCT, Inc
11.3.1 Company overview
11.3.2 Company snapshot
11.3.3 Operating business segments
11.3.4 Product portfolio
11.3.5 Business performance
11.3.6 Key strategic moves and developments
11.4 Asahi Kasei Medical Co., Ltd
11.4.1 Company overview
11.4.2 Company snapshot
11.4.3 Operating business segments
11.4.4 Product portfolio
11.4.5 Business performance
11.4.6 Key strategic moves and developments
11.5 Kaneka Corporation
11.5.1 Company overview
11.5.2 Company snapshot
11.5.3 Operating business segments
11.5.4 Product portfolio
11.5.5 Business performance
11.5.6 Key strategic moves and developments
11.6 Kawasumi Laboratories Inc
11.6.1 Company overview
11.6.2 Company snapshot
11.6.3 Operating business segments
11.6.4 Product portfolio
11.6.5 Business performance
11.6.6 Key strategic moves and developments
11.7 Cerus Corporation
11.7.1 Company overview
11.7.2 Company snapshot
11.7.3 Operating business segments
11.7.4 Product portfolio
11.7.5 Business performance
11.7.6 Key strategic moves and developments
11.8 B. Braun Melsungen AG
11.8.1 Company overview
11.8.2 Company snapshot
11.8.3 Operating business segments
11.8.4 Product portfolio
11.8.5 Business performance
11.8.6 Key strategic moves and developments
11.9 Nikkiso Co., Ltd
11.9.1 Company overview
11.9.2 Company snapshot
11.9.3 Operating business segments
11.9.4 Product portfolio
11.9.5 Business performance
11.9.6 Key strategic moves and developments
11.10 Charles River Laboratories International, Inc.
11.10.1 Company overview
11.10.2 Company snapshot
11.10.3 Operating business segments
11.10.4 Product portfolio
11.10.5 Business performance
11.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Apheresis Market, by Product, 2021-2031 ($Million)
Table 2. Apheresis Market Size, for Devices, by Region, 2021-2031 ($Million)
Table 3. Apheresis Market for Devices by Country, 2021-2031 ($Million)
Table 4. Apheresis Market Size, for Disposable and Reagents, by Region, 2021-2031 ($Million)
Table 5. Apheresis Market for Disposable and Reagents by Country, 2021-2031 ($Million)
Table 6. Apheresis Market Size, for Software, by Region, 2021-2031 ($Million)
Table 7. Apheresis Market for Software by Country, 2021-2031 ($Million)
Table 8. Global Apheresis Market, by Method, 2021-2031 ($Million)
Table 9. Apheresis Market Size, for Centrifugation, by Region, 2021-2031 ($Million)
Table 10. Apheresis Market for Centrifugation by Country, 2021-2031 ($Million)
Table 11. Apheresis Market Size, for Membrane Separation, by Region, 2021-2031 ($Million)
Table 12. Apheresis Market for Membrane Separation by Country, 2021-2031 ($Million)
Table 13. Apheresis Market Size, for Selective Adsorption, by Region, 2021-2031 ($Million)
Table 14. Apheresis Market for Selective Adsorption by Country, 2021-2031 ($Million)
Table 15. Global Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 16. Apheresis Market Size, for Donor/Automated Apheresis, by Region, 2021-2031 ($Million)
Table 17. Apheresis Market for Donor/Automated Apheresis by Country, 2021-2031 ($Million)
Table 18. Apheresis Market Size, for Therapeutic Apheresis, by Region, 2021-2031 ($Million)
Table 19. Apheresis Market for Therapeutic Apheresis by Country, 2021-2031 ($Million)
Table 20. Global Apheresis Market, by Component, 2021-2031 ($Million)
Table 21. Apheresis Market Size, for Plasma (Plasmapheresis), by Region, 2021-2031 ($Million)
Table 22. Apheresis Market for Plasma (Plasmapheresis) by Country, 2021-2031 ($Million)
Table 23. Apheresis Market Size, for Platelets (Plateletpheresis), by Region, 2021-2031 ($Million)
Table 24. Apheresis Market for Platelets (Plateletpheresis) by Country, 2021-2031 ($Million)
Table 25. Apheresis Market Size, for Leukocytes (Leukapheresis or Leukopheresis), by Region, 2021-2031 ($Million)
Table 26. Apheresis Market for Leukocytes (Leukapheresis or Leukopheresis) by Country, 2021-2031 ($Million)
Table 27. Apheresis Market Size, for Lymphocytes (Lymphopheresis or Lymphapheresis), by Region, 2021-2031 ($Million)
Table 28. Apheresis Market for Lymphocytes (Lymphopheresis or Lymphapheresis) by Country, 2021-2031 ($Million)
Table 29. Apheresis Market Size, for Rbc's (Erythropheresis), by Region, 2021-2031 ($Million)
Table 30. Apheresis Market for Rbc's (Erythropheresis) by Country, 2021-2031 ($Million)
Table 31. Global Apheresis Market, by End-user, 2021-2031 ($Million)
Table 32. Apheresis Market Size, for Blood Centers, by Region, 2021-2031 ($Million)
Table 33. Apheresis Market for Blood Centers by Country, 2021-2031 ($Million)
Table 34. Apheresis Market Size, for Hospitals, by Region, 2021-2031 ($Million)
Table 35. Apheresis Market for Hospitals by Country, 2021-2031 ($Million)
Table 36. Apheresis Market Size, for Other End-users, by Region, 2021-2031 ($Million)
Table 37. Apheresis Market for Other End-users by Country, 2021-2031 ($Million)
Table 38. Apheresis Market, by Region, 2021-2031 ($Million)
Table 39. North America Apheresis Market, by Product, 2021-2031 ($Million)
Table 40. North America Apheresis Market, by Method, 2021-2031 ($Million)
Table 41. North America Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 42. North America Apheresis Market, by Component, 2021-2031 ($Million)
Table 43. North America Apheresis Market, by End-user, 2021-2031 ($Million)
Table 44. North America Apheresis Market, by Country, 2021-2031 ($Million)
Table 45. U.S. Apheresis Market, by Product, 2021-2031 ($Million)
Table 46. U.S. Apheresis Market, by Method, 2021-2031 ($Million)
Table 47. U.S. Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 48. U.S. Apheresis Market, by Component, 2021-2031 ($Million)
Table 49. U.S. Apheresis Market, by End-user, 2021-2031 ($Million)
Table 50. Canada Apheresis Market, by Product, 2021-2031 ($Million)
Table 51. Canada Apheresis Market, by Method, 2021-2031 ($Million)
Table 52. Canada Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 53. Canada Apheresis Market, by Component, 2021-2031 ($Million)
Table 54. Canada Apheresis Market, by End-user, 2021-2031 ($Million)
Table 55. Mexico Apheresis Market, by Product, 2021-2031 ($Million)
Table 56. Mexico Apheresis Market, by Method, 2021-2031 ($Million)
Table 57. Mexico Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 58. Mexico Apheresis Market, by Component, 2021-2031 ($Million)
Table 59. Mexico Apheresis Market, by End-user, 2021-2031 ($Million)
Table 60. Europe Apheresis Market, by Product, 2021-2031 ($Million)
Table 61. Europe Apheresis Market, by Method, 2021-2031 ($Million)
Table 62. Europe Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 63. Europe Apheresis Market, by Component, 2021-2031 ($Million)
Table 64. Europe Apheresis Market, by End-user, 2021-2031 ($Million)
Table 65. Europe Apheresis Market, by Country, 2021-2031 ($Million)
Table 66. Germany Apheresis Market, by Product, 2021-2031 ($Million)
Table 67. Germany Apheresis Market, by Method, 2021-2031 ($Million)
Table 68. Germany Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 69. Germany Apheresis Market, by Component, 2021-2031 ($Million)
Table 70. Germany Apheresis Market, by End-user, 2021-2031 ($Million)
Table 71. France Apheresis Market, by Product, 2021-2031 ($Million)
Table 72. France Apheresis Market, by Method, 2021-2031 ($Million)
Table 73. France Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 74. France Apheresis Market, by Component, 2021-2031 ($Million)
Table 75. France Apheresis Market, by End-user, 2021-2031 ($Million)
Table 76. U.K. Apheresis Market, by Product, 2021-2031 ($Million)
Table 77. U.K. Apheresis Market, by Method, 2021-2031 ($Million)
Table 78. U.K. Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 79. U.K. Apheresis Market, by Component, 2021-2031 ($Million)
Table 80. U.K. Apheresis Market, by End-user, 2021-2031 ($Million)
Table 81. Italy Apheresis Market, by Product, 2021-2031 ($Million)
Table 82. Italy Apheresis Market, by Method, 2021-2031 ($Million)
Table 83. Italy Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 84. Italy Apheresis Market, by Component, 2021-2031 ($Million)
Table 85. Italy Apheresis Market, by End-user, 2021-2031 ($Million)
Table 86. Spain Apheresis Market, by Product, 2021-2031 ($Million)
Table 87. Spain Apheresis Market, by Method, 2021-2031 ($Million)
Table 88. Spain Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 89. Spain Apheresis Market, by Component, 2021-2031 ($Million)
Table 90. Spain Apheresis Market, by End-user, 2021-2031 ($Million)
Table 91. Rest of Europe Apheresis Market, by Product, 2021-2031 ($Million)
Table 92. Rest of Europe Apheresis Market, by Method, 2021-2031 ($Million)
Table 93. Rest of Europe Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 94. Rest of Europe Apheresis Market, by Component, 2021-2031 ($Million)
Table 95. Rest of Europe Apheresis Market, by End-user, 2021-2031 ($Million)
Table 96. Asia-Pacific Apheresis Market, by Product, 2021-2031 ($Million)
Table 97. Asia-Pacific Apheresis Market, by Method, 2021-2031 ($Million)
Table 98. Asia-Pacific Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 99. Asia-Pacific Apheresis Market, by Component, 2021-2031 ($Million)
Table 100. Asia-Pacific Apheresis Market, by End-user, 2021-2031 ($Million)
Table 101. Asia-Pacific Apheresis Market, by Country, 2021-2031 ($Million)
Table 102. Japan Apheresis Market, by Product, 2021-2031 ($Million)
Table 103. Japan Apheresis Market, by Method, 2021-2031 ($Million)
Table 104. Japan Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 105. Japan Apheresis Market, by Component, 2021-2031 ($Million)
Table 106. Japan Apheresis Market, by End-user, 2021-2031 ($Million)
Table 107. China Apheresis Market, by Product, 2021-2031 ($Million)
Table 108. China Apheresis Market, by Method, 2021-2031 ($Million)
Table 109. China Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 110. China Apheresis Market, by Component, 2021-2031 ($Million)
Table 111. China Apheresis Market, by End-user, 2021-2031 ($Million)
Table 112. India Apheresis Market, by Product, 2021-2031 ($Million)
Table 113. India Apheresis Market, by Method, 2021-2031 ($Million)
Table 114. India Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 115. India Apheresis Market, by Component, 2021-2031 ($Million)
Table 116. India Apheresis Market, by End-user, 2021-2031 ($Million)
Table 117. Australia Apheresis Market, by Product, 2021-2031 ($Million)
Table 118. Australia Apheresis Market, by Method, 2021-2031 ($Million)
Table 119. Australia Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 120. Australia Apheresis Market, by Component, 2021-2031 ($Million)
Table 121. Australia Apheresis Market, by End-user, 2021-2031 ($Million)
Table 122. South Korea Apheresis Market, by Product, 2021-2031 ($Million)
Table 123. South Korea Apheresis Market, by Method, 2021-2031 ($Million)
Table 124. South Korea Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 125. South Korea Apheresis Market, by Component, 2021-2031 ($Million)
Table 126. South Korea Apheresis Market, by End-user, 2021-2031 ($Million)
Table 127. Rest of Asia-Pacific Apheresis Market, by Product, 2021-2031 ($Million)
Table 128. Rest of Asia-Pacific Apheresis Market, by Method, 2021-2031 ($Million)
Table 129. Rest of Asia-Pacific Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 130. Rest of Asia-Pacific Apheresis Market, by Component, 2021-2031 ($Million)
Table 131. Rest of Asia-Pacific Apheresis Market, by End-user, 2021-2031 ($Million)
Table 132. LAMEA Apheresis Market, by Product, 2021-2031 ($Million)
Table 133. LAMEA Apheresis Market, by Method, 2021-2031 ($Million)
Table 134. LAMEA Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 135. LAMEA Apheresis Market, by Component, 2021-2031 ($Million)
Table 136. LAMEA Apheresis Market, by End-user, 2021-2031 ($Million)
Table 137. LAMEA Apheresis Market, by Country, 2021-2031 ($Million)
Table 138. Brazil Apheresis Market, by Product, 2021-2031 ($Million)
Table 139. Brazil Apheresis Market, by Method, 2021-2031 ($Million)
Table 140. Brazil Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 141. Brazil Apheresis Market, by Component, 2021-2031 ($Million)
Table 142. Brazil Apheresis Market, by End-user, 2021-2031 ($Million)
Table 143. Saudi Arabia Apheresis Market, by Product, 2021-2031 ($Million)
Table 144. Saudi Arabia Apheresis Market, by Method, 2021-2031 ($Million)
Table 145. Saudi Arabia Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 146. Saudi Arabia Apheresis Market, by Component, 2021-2031 ($Million)
Table 147. Saudi Arabia Apheresis Market, by End-user, 2021-2031 ($Million)
Table 148. South Africa Apheresis Market, by Product, 2021-2031 ($Million)
Table 149. South Africa Apheresis Market, by Method, 2021-2031 ($Million)
Table 150. South Africa Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 151. South Africa Apheresis Market, by Component, 2021-2031 ($Million)
Table 152. South Africa Apheresis Market, by End-user, 2021-2031 ($Million)
Table 153. Rest of LAMEA Apheresis Market, by Product, 2021-2031 ($Million)
Table 154. Rest of LAMEA Apheresis Market, by Method, 2021-2031 ($Million)
Table 155. Rest of LAMEA Apheresis Market, by Procedure, 2021-2031 ($Million)
Table 156. Rest of LAMEA Apheresis Market, by Component, 2021-2031 ($Million)
Table 157. Rest of LAMEA Apheresis Market, by End-user, 2021-2031 ($Million)
Table 158. Haemonetics Corporation: Company Snapshot
Table 159. Haemonetics Corporation: Operating Segments
Table 160. Haemonetics Corporation: Product Portfolio
Table 161. Haemonetics Corporation: Net Sales
Table 162. Haemonetics Corporation: Key Stratergies
Table 163. Fresenius Kabi: Company Snapshot
Table 164. Fresenius Kabi: Operating Segments
Table 165. Fresenius Kabi: Product Portfolio
Table 166. Fresenius Kabi: Net Sales
Table 167. Fresenius Kabi: Key Stratergies
Table 168. Terumo Bct, Inc: Company Snapshot
Table 169. Terumo Bct, Inc: Operating Segments
Table 170. Terumo Bct, Inc: Product Portfolio
Table 171. Terumo Bct, Inc: Net Sales
Table 172. Terumo Bct, Inc: Key Stratergies
Table 173. Asahi Kasei Medical Co., Ltd: Company Snapshot
Table 174. Asahi Kasei Medical Co., Ltd: Operating Segments
Table 175. Asahi Kasei Medical Co., Ltd: Product Portfolio
Table 176. Asahi Kasei Medical Co., Ltd: Net Sales
Table 177. Asahi Kasei Medical Co., Ltd: Key Stratergies
Table 178. Kaneka Corporation: Company Snapshot
Table 179. Kaneka Corporation: Operating Segments
Table 180. Kaneka Corporation: Product Portfolio
Table 181. Kaneka Corporation: Net Sales
Table 182. Kaneka Corporation: Key Stratergies
Table 183. Kawasumi Laboratories Inc: Company Snapshot
Table 184. Kawasumi Laboratories Inc: Operating Segments
Table 185. Kawasumi Laboratories Inc: Product Portfolio
Table 186. Kawasumi Laboratories Inc: Net Sales
Table 187. Kawasumi Laboratories Inc: Key Stratergies
Table 188. Cerus Corporation: Company Snapshot
Table 189. Cerus Corporation: Operating Segments
Table 190. Cerus Corporation: Product Portfolio
Table 191. Cerus Corporation: Net Sales
Table 192. Cerus Corporation: Key Stratergies
Table 193. B. Braun Melsungen Ag: Company Snapshot
Table 194. B. Braun Melsungen Ag: Operating Segments
Table 195. B. Braun Melsungen Ag: Product Portfolio
Table 196. B. Braun Melsungen Ag: Net Sales
Table 197. B. Braun Melsungen Ag: Key Stratergies
Table 198. Nikkiso Co., Ltd: Company Snapshot
Table 199. Nikkiso Co., Ltd: Operating Segments
Table 200. Nikkiso Co., Ltd: Product Portfolio
Table 201. Nikkiso Co., Ltd: Net Sales
Table 202. Nikkiso Co., Ltd: Key Stratergies
Table 203. Charles River Laboratories International, Inc.: Company Snapshot
Table 204. Charles River Laboratories International, Inc.: Operating Segments
Table 205. Charles River Laboratories International, Inc.: Product Portfolio
Table 206. Charles River Laboratories International, Inc.: Net Sales
Table 207. Charles River Laboratories International, Inc.: Key Stratergies
LIST OF FIGURES
Figure 1. Apheresis Market Segmentation
Figure 2. Apheresis Market, 2021-2031
Figure 3. Apheresis Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Apheresis Market:Drivers, Restraints and Opportunities
Figure 12. Apheresis Market, by Product, 2021 (%)
Figure 13. Comparative Share Analysis of Devices Apheresis Market, 2021-2031 (%)
Figure 14. Comparative Share Analysis of Disposable and Reagents Apheresis Market, 2021-2031 (%)
Figure 15. Comparative Share Analysis of Software Apheresis Market, 2021-2031 (%)
Figure 16. Apheresis Market, by Method, 2021 (%)
Figure 17. Comparative Share Analysis of Centrifugation Apheresis Market, 2021-2031 (%)
Figure 18. Comparative Share Analysis of Membrane Separation Apheresis Market, 2021-2031 (%)
Figure 19. Comparative Share Analysis of Selective Adsorption Apheresis Market, 2021-2031 (%)
Figure 20. Apheresis Market, by Procedure, 2021 (%)
Figure 21. Comparative Share Analysis of Donor/Automated Apheresis Apheresis Market, 2021-2031 (%)
Figure 22. Comparative Share Analysis of Therapeutic Apheresis Apheresis Market, 2021-2031 (%)
Figure 23. Apheresis Market, by Component, 2021 (%)
Figure 24. Comparative Share Analysis of Plasma (Plasmapheresis) Apheresis Market, 2021-2031 (%)
Figure 25. Comparative Share Analysis of Platelets (Plateletpheresis) Apheresis Market, 2021-2031 (%)
Figure 26. Comparative Share Analysis of Leukocytes (Leukapheresis or Leukopheresis) Apheresis Market, 2021-2031 (%)
Figure 27. Comparative Share Analysis of Lymphocytes (Lymphopheresis or Lymphapheresis) Apheresis Market, 2021-2031 (%)
Figure 28. Comparative Share Analysis of Rbc's (Erythropheresis) Apheresis Market, 2021-2031 (%)
Figure 29. Apheresis Market, by End-user, 2021 (%)
Figure 30. Comparative Share Analysis of Blood Centers Apheresis Market, 2021-2031 (%)
Figure 31. Comparative Share Analysis of Hospitals Apheresis Market, 2021-2031 (%)
Figure 32. Comparative Share Analysis of Other End-users Apheresis Market, 2021-2031 (%)
Figure 33. Apheresis Market by Region, 2021
Figure 34. U.S. Apheresis Market, 2021-2031 ($Million)
Figure 35. Canada Apheresis Market, 2021-2031 ($Million)
Figure 36. Mexico Apheresis Market, 2021-2031 ($Million)
Figure 37. Germany Apheresis Market, 2021-2031 ($Million)
Figure 38. France Apheresis Market, 2021-2031 ($Million)
Figure 39. U.K. Apheresis Market, 2021-2031 ($Million)
Figure 40. Italy Apheresis Market, 2021-2031 ($Million)
Figure 41. Spain Apheresis Market, 2021-2031 ($Million)
Figure 42. Rest of Europe Apheresis Market, 2021-2031 ($Million)
Figure 43. Japan Apheresis Market, 2021-2031 ($Million)
Figure 44. China Apheresis Market, 2021-2031 ($Million)
Figure 45. India Apheresis Market, 2021-2031 ($Million)
Figure 46. Australia Apheresis Market, 2021-2031 ($Million)
Figure 47. South Korea Apheresis Market, 2021-2031 ($Million)
Figure 48. Rest of Asia-Pacific Apheresis Market, 2021-2031 ($Million)
Figure 49. Brazil Apheresis Market, 2021-2031 ($Million)
Figure 50. Saudi Arabia Apheresis Market, 2021-2031 ($Million)
Figure 51. South Africa Apheresis Market, 2021-2031 ($Million)
Figure 52. Rest of LAMEA Apheresis Market, 2021-2031 ($Million)
Figure 53. Top Winning Strategies, by Year
Figure 54. Top Winning Strategies, by Development
Figure 55. Top Winning Strategies, by Company
Figure 56. Product Mapping of Top 10 Players
Figure 57. Competitive Dashboard
Figure 58. Competitive Heatmap of Top 10 Key Players
Figure 59. Haemonetics Corporation.: Net Sales, ($Million)
Figure 60. Fresenius Kabi.: Net Sales, ($Million)
Figure 61. Terumo Bct, Inc.: Net Sales, ($Million)
Figure 62. Asahi Kasei Medical Co. Ltd.: Net Sales, ($Million)
Figure 63. Kaneka Corporation.: Net Sales, ($Million)
Figure 64. Kawasumi Laboratories Inc.: Net Sales, ($Million)
Figure 65. Cerus Corporation.: Net Sales, ($Million)
Figure 66. B. Braun Melsungen AG.: Net Sales, ($Million)
Figure 67. Nikkiso Co. Ltd.: Net Sales, ($Million)
Figure 68. Charles River Laboratories International, Inc. Net Sales, ($Million)

Executive Summary

According to this report titled, 'Apheresis Market,' the apheresis market was valued at $2.4 billion in 2021, and is estimated to reach $5.3 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031.
Apheresis procedures involve separation of desired components from the blood, while the remaining is either returned to the donor or the patient body. The whole blood is transformed within an instrument that is essentially designed as a centrifuge, the components of whole blood are separated. One of the separated portions is then withdrawn and the remaining components are re-transfused into the patient or donor. There are various methods such as centrifugation, membrane separation, and selective adsorption that are used for apheresis.
The key Apheresis market trends that drive the market growth include, rise in the demand for blood components across the globe, and government initiative for the blood donation camp. In addition, there is approval for apheresis treatment such as cardiac neonatal lupus, autoimmune hemolytic anemia and acute disseminated encephalomyelitis supplement the Apheresis market growth. Plasma donation treatment has increased in the treatment of burnt patients, trauma patients, and patients suffering from serious disorders or major injuries, which drives the growth of the market. The global apheresis equipment is primarily driven by increase in incidence of chronic diseases worldwide, rise in number of platelet donors, and spike in R&D investments made by biotech and pharmaceutical companies. In October 2020, Hemonetics, blood management product company, received product approval from FDA (Food and Drug Administration) for NexSys PCS with persona technology, which customizes plasma collection based on an individual donor's body composition.
Plasma is widely used in renal & metabolic diseases and hematologic & neurologic disorders, which helps the market to grow. The disposable products that are used in apheresis drive the market and contribute to the highest growth as there are extensive advancements that are taking place in the development of blood bags, tubing, and disposable kits; however, the same segment is expected to witness considerable growth during the forecast period. There is increase in the platelets donation and plasma donation, which drives the growth of the market.
COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The apheresis market is expected to be positively impacted during the COVID-19 pandemic owing to the extensive application of plasma therapy in the treatment of COVID-19 infected patients.

Apheresis market is segmented into product, method, procedure, component, end user, and region. On the basis of product, the market is classified into devices, disposable & reagents, and software. By method, it is categorized into centrifugation, membrane separation, and selective adsorption. Depending on procedure, it is divided into donor/automated apheresis and therapeutic apheresis. According to component, it is fragmented into plasma (plasmapheresis), platelets (plateletpheresis), leukocytes (leukapheresis), lymphocytes (lymph apheresis), and RBCS (erythropheresis). Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Based on product, the disposable & reagent segment has largest market share in 2021, and this trend is expected to continue during the forecast period, due to the extensive advancements that are taking place in the development of blood bags, tubing, and disposable kits. However, the same segment is expected to witness considerable growth during the forecast period.
By procedure, the donor/automated segment dominated the market in 2021, and this trend is expected to continue during the forecast period, as blood centers have major share in the global apheresis market, which supplement the growth of the donor apheresis segment. Furthermore, surge in apheresis platelet donation and apheresis plasma donations have contributed to the market growth.

However, the therapeutic apheresis segment is expected to witness considerable growth during the forecast period. Owing to rise in patient base suffering from chronic disorders, apheresis is performed for the removal of disease mediator in plasma (autologous/allogenic antibodies), removal diseased cells (sickle or parasite-infected red cells), removal of excess cells (essential thrombocythemia), and replacement with normal blood components.
By method, the centrifugation segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to the predominant use of centrifugation in the preparation of blood components such as packed red blood cells (PRBCs) and fresh frozen plasma (FFP) in a single-step heavy spin.

However, the membrane separation segment is expected to witness considerable growth during the forecast period, as membrane filters play a pivotal role in filtration of plasma from other cellular components to achieve specific cell separation.

By component, the plasma (plasmapheresis) segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing to its wide utilization across renal & metabolic diseases and hematologic & neurologic disorders.

However, the platelet pheresis segment is expected to witness considerable growth during the forecast period, due to soaring number of platelet apheresis procedures across the globe.

By end user, blood centers segment dominated the Apheresis market share in 2021, and this trend is expected to continue during the forecast period, as donor apheresis forms a major constituent of the apheresis industry, and maximum donor apheresis procedures are performed in the blood centers across the globe.

However, the other end user segment is expected to witness considerable growth during the forecast period, as biopharmaceutical manufacturers are the major contributors to the robust growth of this segment, owing to increase in demand for plasma-based drugs.

Region-wise, North America dominated the Apheresis market size in 2021, and is expected to be dominant during the forecast period, owing to the early adoption of novel apheresis systems and increase in prevalence of blood-related disorders in this region.
However, Asia-Pacific is expected to register highest CAGR of 9.3% from 2022 to 2030, owing to presence of high population base and increase in geriatric population (more susceptible to chronic injuries and disorders).

KEY FINDINGS OF THE STUDY

  • By product, the disposable & reagent segment was the highest contributor to the market in 2021.
  • On the basis of procedure, the donor/automated segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • On the basis of method, the centrifugation segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • On the basis of component, the plasma (plasmapheresis) segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • On the basis of end user, blood centers segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
  • Region-wise, North America garnered the largest revenue share in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • Haemonetics Corporation
  • Fresenius Kabi
  • Terumo BCT, Inc
  • Asahi Kasei Medical Co., Ltd
  • Kaneka Corporation
  • Kawasumi Laboratories Inc
  • Cerus Corporation
  • B. Braun Melsungen AG
  • Nikkiso Co., Ltd
  • Charles River Laboratories International, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages270
PublishedMay 2022
Forecast Period2021 - 2031
Estimated Market Value ( USD ) in 2021 $ 2383.41 million
Forecasted Market Value ( USD ) by 2031 $ 5300.57 million
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Apheresis Market, By Product, By Type, By Procedure, By Technology, By End User, Estimation & Forecast, 2018-2031 - Product Image

Global Apheresis Market, By Product, By Type, By Procedure, By Technology, By End User, Estimation & Forecast, 2018-2031

  • Report
  • 215 Pages
  • Global
From
Global Apheresis Market Report and Forecast 2023-2031 - Product Image

Global Apheresis Market Report and Forecast 2023-2031

  • Report
  • 160 Pages
  • Global
From
Apheresis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Apheresis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 132 Pages
  • Global
From
Global Apheresis Equipment Market Size, Share & Trends Analysis Report by Application (Renal Diseases, Neurology), Procedure (LDL-Apheresis, Leukapheresis), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Apheresis Equipment Market Size, Share & Trends Analysis Report by Application (Renal Diseases, Neurology), Procedure (LDL-Apheresis, Leukapheresis), Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Apheresis Equipment - Global Strategic Business Report - Product Image

Apheresis Equipment - Global Strategic Business Report

  • Report
  • 604 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.